Skip to main content

Day: March 29, 2022

urban-gro, Inc. Reports Record Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Full Year Guidance

Record fourth quarter revenue of $19.0 million, representing growth of 106% compared to the prior year period; organic revenue growth was 77.6%, excluding contribution from the 2WR+ acquisition. Full year 2021 revenue was $62.1 million, representing growth of 140%. Fourth quarter net loss of ($0.6) million; full year 2021 net loss was ($0.9) million Fourth quarter Adjusted EBITDA1 of $0.5 million; full year 2021 Adjusted EBITDA of $2.7 million, representing an Adjusted EBITDA margin of 4.3% of revenue Project backlog of contractually committed equipment and service orders with deposits received was $30.2 million as of December 31, 2021 Strong balance sheet with $34.6 million in cash and no debt Provides 2022 revenue guidance of greater than $110 million and Adjusted EBITDA guidance of greater than $5.0 million, including partial year...

Continue reading

HTG Molecular Diagnostics Reports Full Year 2021 Results

Call scheduled for today, March 29, at 4:30 pm ET TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its financial results for the year ended December 31, 2021. Recent Business HighlightsHTG Transcriptome Panel (“HTP”) revenue continued to increase in the fourth quarter of 2021, ending the year as the top selling assay at approximately 16% of total revenue, just 5 months after commercial sales availability.Announced the expansion of its therapeutics team with the addition of several highly experienced professionals, led by Stephen Barat, Ph.D., a drug development veteran who most recently served with the Janssen Pharmaceutical Companies of Johnson...

Continue reading

TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2021 Financial Results

FREDERICK, Md., March 29, 2022 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its financial results for the fourth quarter and year ended December 31, 2021. TOMI Chief Executive Officer, Dr. Halden Shane, stated, “Over the last two years, our Company has made dramatic progress growing our customer list, diversifying our product line through internal innovation, enhancing brand recognition, and positioning TOMI as a major player in the disinfection markets. As expected, 2021 revenue decreased from the previous year because 2020 saw a surge in demand for disinfection products at the onset of the COVID-19 pandemic....

Continue reading

Stronghold Digital Mining Reports Fourth Quarter and Year-End 2021 Results and Provides Operational Update

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (Nasdaq: SDIG) (“Stronghold,” or the “Company”) today reported financial results for its fourth quarter and full year ended December 31, 2021, and provided an operational update. Fourth Quarter and Year-End 2021 and Recent Operational and Financial HighlightsRemoved approximately 264,561 tons of coal refuse and returned approximately 141,876 tons of beneficial use ash to waste coal sites during the fourth quarter, facilitating the remediation of these sites. As of December 31, 2021, we had received a total of 14,700 miners with total hash rate capacity of approximately 1.3 exahash per second (“EH/s”). As of March 24, 2022, we had received approximately 25,200 miners with total hash rate capacity of approximately 2.3 EH/s. As of March 24, 2022, we have...

Continue reading

Senvest Capital Reports Results for the Year Ended December 31, 2021

MONTREAL, March 29, 2022 (GLOBE NEWSWIRE) — Senvest Capital Inc. today reported net income attributable to common shareholders of $733.0 million or $289.32 per share for the year ended December 31, 2021. This compares to net income attributable to common shareholders of $211.7 million or $80.66 per share for the year 2020. Financial statements are available online at Sedar www.sedar.com CONSOLIDATED STATEMENTS OF INCOME (in millions of dollars, except per share amounts) For the years ended       December 31, 2021 December 31, 2020     Net income attributable to common shareholders $733.0 $211.7     Diluted earnings per share attributable to common shareholders $289.32 $80.66Contact: George MalikotsisVice President Finance(514) 281-8082www.senvest.com

Continue reading

CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

Conference call and webcast at 5:00 p.m. ET today, March 29, 2022 MENLO PARK, Calif., March 29, 2022 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, today reported its financial results for the fourth quarter and full year ended December 31, 2021 and provided a corporate update. “2021 was a year of significant growth for CohBar, highlighted by positive topline data from our first human study and the demonstration of clinical proof-of-concept for our platform, the nomination of our second clinical candidate, and the addition of high-quality talent to our leadership and Board,” stated Dr. Joseph Sarret, Chief Executive Officer....

Continue reading

Sportsman’s Warehouse Holdings, Inc. Announces Fourth Quarter and Record Fiscal Year 2021 Financial Results

WEST JORDAN, Utah, March 29, 2022 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) today announced financial results for the thirteen and fifty-two weeks ended January 29, 2022. “We are very pleased with our performance for the fourth quarter as we exceeded our guidance given earlier in the year,” said Jon Barker, Sportsman’s Warehouse CEO. “While there was some softening in our shooting sports category in 2021, our business fundamentals remain strong, with growth in all our other categories, led by double-digit growth in footwear and apparel. We also expanded our footprint by opening 10 new stores during the year, refurbished another 19 stores, and grew our e-commerce business to over 15% of net sales, successfully executing on our strategic...

Continue reading

Eimskip: Allocation of share options

The Board of Directors of Eimskipafélag Íslands hf. decided today to allocate share options to certain key employees of the company globally amounting to 1,839,600 shares, which constitutes 1.05% of Eimskip’s share capital when the share option plan was approved. Thereof 1,090,620 was allocated to the CEO and Executive Management and the respective agreements signed today. The share option plan sets forth a long-term incentive program intended to align the interests of the CEO, Executive Management and other key employees of the company, on one hand, and its shareholders, on the other hand, with a system which takes capital costs into account and adjusts for dividend payments, and as such seeks the equality of share option holders and shareholders. The terms and conditions of the share option agreements are in line with the share option...

Continue reading

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement COPENHAGEN, Denmark; March 29, 2022 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on March 29, 2022, the Company’s Board of Directors met to constitute itself. Ms. Deirdre P. Connelly was appointed Chair and Ms. Pernille Erenbjerg was appointed Deputy Chair. It was decided to grant 13,187 restricted stock units to the new member of the Board of Directors and employees of the Company and the Company’s subsidiaries and 13,912 warrants to the employees of the Company and the Company’s subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a right and obligation to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the date of grant of one Genmab A/S share, DKK 2,408. The...

Continue reading

Nokia Corporation: Repurchase of own shares on 29.03.2022

Nokia CorporationStock Exchange Release29 March 2022 at 21:00 EET Nokia Corporation: Repurchase of own shares on 29.03.2022 Espoo, Finland – On 29 March 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 255,846 5.01CEUX 7,466 5.00AQEU 2,619 5.01TQEX 4,069 5.00Total 270,000 5.01* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the current authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in traches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.